Bendamustine plus rituximab for the treatment of Waldenström Macroglobulinemia: Patient outcomes and impact of bendamustine dosing

Suzanne O. Arulogun*, Duncan Brian, Harshita Goradia, Aaron Cooney, Tobias Menne, Ray Mun Koo, Aideen T. O'Neill, Josephine M.I. Vos, Guy Pratt, Deborah Turner, Kirsty Marshall, Kate Manos, Claire Anderson, Maria Gavriatopoulou, Charalampia Kyriakou, Marie J. Kersten, Monique C. Minnema, Eirini Koutoumanou, Dima El-Sharkawi, Kim LintonDipti Talaulikar, Helen McCarthy, Mark Bishton, George Follows, Ashutosh Wechalekar, Shirley P. D'Sa

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    5 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Bendamustine plus rituximab for the treatment of Waldenström Macroglobulinemia: Patient outcomes and impact of bendamustine dosing'. Together they form a unique fingerprint.

    Medicine and Dentistry

    Pharmacology, Toxicology and Pharmaceutical Science

    Immunology and Microbiology